SLV-313 SR

DRUG2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Healthy

Phase 1

Study Evaluating Safety and Tolerability of Ascending Multiple Dose of SLV-313 in Schizophrenia Patients

TerminatedNCT00581243

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2008-01-01End: 2008-05-01Updated: 2022-05-03

Study Evaluating Multiple Ascending Dose in Schizophrenia Patients

TerminatedNCT00620568

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2008-02-29End: 2008-03-31Target: 32Updated: 2009-08-04